Updated: January 23, 2026
Levamlodipine Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Levamlodipine (Conjupri) generally has fewer side effects than amlodipine. Learn what to expect, what's normal, and which side effects require urgent medical attention.
Levamlodipine (brand name Conjupri) is generally well tolerated, with a side effect profile that is improved compared to its parent drug, racemic amlodipine. In a postmarketing surveillance study of 1,859 patients, only 30 (about 1.6%) reported any side effects. Still, like all medications, levamlodipine can cause unwanted effects in some people. Knowing what to expect—and knowing the difference between common, minor side effects and those that require a call to your doctor—is essential for safe, confident use of this medication.
Why Levamlodipine Has Fewer Side Effects Than Amlodipine
Amlodipine is a 50/50 mixture of two mirror-image molecules: (S)-amlodipine (levamlodipine) and (R)-amlodipine. Only the (S)-form has therapeutic activity—it blocks calcium channels and lowers blood pressure. The (R)-form doesn't contribute to blood pressure reduction but may contribute to some side effects. By using only the (S)-enantiomer, levamlodipine can achieve the same therapeutic effect at half the dose, which reduces exposure to inactive compound and is associated with a lower incidence of peripheral edema and other dose-related side effects.
Common Side Effects (Usually Mild and Manageable)
The following side effects are reported by some patients, particularly when first starting the medication or when the dose is increased. They often improve as your body adjusts:
Peripheral edema (swelling): Swelling in the feet, ankles, or lower legs. This is the most well-known side effect of calcium channel blockers like levamlodipine, though it occurs far less frequently with levamlodipine than with amlodipine.
Dizziness or lightheadedness: More common when first starting the medication or after a dose increase. Stand up slowly from a seated or lying position to reduce this effect.
Fatigue: Some patients feel more tired than usual, especially early in treatment.
Flushing: Warmth, redness, or a tingling sensation in the skin, often in the face. Usually mild and temporary.
Headache: Can occur, particularly when the body is adjusting to the blood pressure-lowering effect.
Nausea: Mild stomach upset reported by some patients. Taking levamlodipine with or without food is acceptable—neither affects the drug's absorption.
Less Common Side Effects
Occurring in less than 1% of patients but still worth knowing about:
Arrhythmia (irregular heartbeat) — contact your doctor if you notice palpitations or irregular pulse
Gingival hyperplasia (gum overgrowth) — rare but associated with calcium channel blockers; maintain good dental hygiene
Rash or skin reactions — notify your doctor if you develop an unexplained rash
Sexual dysfunction — less common but reported with this drug class
Constipation, dry mouth, or other gastrointestinal symptoms
Serious Side Effects: Call Your Doctor Right Away
The following symptoms are rare but serious. Seek immediate medical attention if you experience:
Severe low blood pressure (hypotension): Extreme dizziness, feeling faint, pale skin, or fainting. Higher risk in patients with severe aortic stenosis.
Worsening chest pain (angina) or signs of heart attack: Crushing chest pain, pain radiating to the jaw or left arm, sweating, nausea. This is most likely to occur when first starting levamlodipine in patients with severe obstructive coronary artery disease. Call 911 immediately.
Severe allergic reaction: Hives, difficulty breathing, swelling of the face, lips, tongue, or throat (angioedema). Stop the medication and go to the nearest emergency room.
Symptoms of liver problems: Yellowing of the skin or eyes (jaundice), dark urine, severe abdominal pain. Very rare, but liver enzyme elevations have been reported.
Who Is at Higher Risk for Side Effects?
Some patients face higher risks for specific side effects:
Patients with severe aortic stenosis: Higher risk of hypotension; requires careful monitoring and slow dose titration.
Patients with severe hepatic impairment: Levamlodipine is metabolized by the liver (approximately 90%); start at 1.25 mg and titrate slowly.
Elderly patients: More sensitive to blood pressure changes; lower starting dose (1.25 mg) recommended.
Patients with severe coronary artery disease: Higher risk of worsening angina when initiating or increasing the dose.
How to Manage Common Side Effects
For edema: Elevate your legs when sitting. If it persists, discuss compression stockings or a dose reduction with your doctor.
For dizziness: Rise slowly from sitting or lying positions. Avoid standing for prolonged periods immediately after doses.
For headache or flushing: These often resolve within a few weeks as your body adapts. Stay hydrated.
The Bottom Line
Levamlodipine is one of the better-tolerated antihypertensives available, with a notably lower rate of peripheral edema than its parent drug amlodipine. Most patients experience no significant side effects. If you do notice symptoms, most are manageable and improve over time. However, always report any new symptoms to your healthcare provider—especially chest pain, fainting, or signs of an allergic reaction. For information on which medications and foods interact with levamlodipine, see our guide on levamlodipine drug interactions.
Frequently Asked Questions
The most commonly reported side effects of levamlodipine include peripheral edema (ankle/leg swelling), dizziness, fatigue, flushing, headache, and nausea. These are generally mild and often improve as the body adjusts. Clinical data show that levamlodipine causes substantially less peripheral edema than racemic amlodipine.
Yes. In clinical studies, nearly 98.7% of patients who switched from amlodipine to levamlodipine due to peripheral edema saw their edema resolve within 4 weeks. The reduced edema profile is levamlodipine's primary clinical advantage over its parent drug.
Call your doctor immediately if you experience: severe dizziness or fainting (possible low blood pressure), chest pain or pressure (possible heart attack), swelling of the face, lips, or throat (possible allergic reaction), or yellowing of the skin or eyes (possible liver problem).
Levamlodipine can worsen angina or, in rare cases, precipitate a heart attack when first starting or increasing the dose—especially in patients with severe obstructive coronary artery disease. This is a class effect of calcium channel blockers. Report any new or worsening chest pain to your doctor immediately.
Yes, but with caution. Elderly patients are more sensitive to blood pressure changes and may be at higher risk for dizziness and falls. The FDA-approved starting dose for elderly patients is 1.25 mg once daily (lower than the standard adult starting dose of 2.5 mg), with careful titration based on response.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Levamlodipine also looked for:
More about Levamlodipine
30,258 have already found their meds with Medfinder.
Start your search today.





